{"id": "1350731921702219776", "creation": 1610874560.0, "user_id": "833942719", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Brazil reported that CoronaVac #vaccine, developed by Beijing-based Sinovac, was 50.4% effective at preventing severe and mild #COVID19 in late-stage trials.\nNota de prensa, 50,4% eficacia #vacuna #covid19 CoronaVac, de Sinovac, China. Ensayo en Brasil.\nhttps://t.co/ptm9EVmU7g", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#VACUNA", "#COVID19"]}